A new portable brain-computer interface, nGoggle, is proving promising for assessing visual function loss in glaucoma patients, said co-inventor Professor Felipe Medeiros from Duke University, North Carolina in an article in Ophthalmology Times.
The total glaucoma market was estimated to be $2.6bn across the seven major markets in 2016 and this is expected to grow to $3.8bn in 2026, at a compound annual growth rate (CAGR) of 4.1%, according to GlobalData, a leading international data and analytics company.
The Volunteer Ophthalmic Services Overseas (VOSO) eye health aid group is adding low vision to its list of aid services from this year and is urgently seeking donations of low vision equipment to distribute in the Pacific Islands to low vision patients.
Eye Surgery Associates has expanded its operations in Auckland with a new location in Manukau joining its two existing clinics on the North Shore and in central Auckland.
CQ Hotel in Wellington has become New Zealand’s first hotel to be awarded a ‘Be. Accessible’ rating for the way it caters for physically, visually and audibly-impaired people. Jai Breitnauer checked it out.
Several ophthalmologists and members of the general public dedicated to helping those with low vision were recognised in this year’s Australia Day honours announcement.
Volunteer Opthalmic Services Overseas (VOSO) spent a week in Tonga at the end of last year at the Vaiola Hospital in Nukuʻalofa. The VOSO team was led by VOSO chair Dr Andrew Riley and included Dr Hussain Patel, VOSO secretary Kylie Dreaver and trustee Hywel Bowen. The team was based at the hospital
Registration is open for the 2018 Ocular Therapeutics Conference. The conference will be held on Sunday 11 March at the Waipuna Conference Centre in Auckland and promises to be even bigger and better than last year’s successful inaugural conference.
Recognising the need for a drug delivery method that reduces patient inconsistency, researchers at the University of California San Francisco (UCSF) have engineered a drug delivery device that slowly releases glaucoma medication, inside the eye for over six months before dissolving away.
A team of researchers from Moorfields Eye Hospital and the UCL Institute of Healthcare Engineering in the UK have been awarded £1.1 million to develop a robotic system to replace damaged retinal cells in people with age-related macular degeneration (AMD).
University of Southern California (USC) scientists have developed an on-the-spot, temperature-sensitive hydrogel and special syringe that can quickly seal eye injuries on the battlefield or in emergency situations.
The Australian National Health and Medical Research Council (NHMRC) has awarded an A$9.46 million grant to Flinders University’s Ophthalmology Eye and Vision Clinic team to help convert genetic
